$NAUT News

Nautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026

Voyager Will Take Center Stage In Nautilus' Commercial Push

Roth Capital Initiates Coverage On Nautilus Biotechnology with Buy Rating, Announces Price Target of $3.5

Nautilus Biotechnology Files $300M Shelf Registration, Including $125M Nasdaq Common Stock ATM Offering Through TD Cowen

Leerink Partners Initiates Coverage On Nautilus Biotechnology with Outperform Rating, Announces Price Target of $4

Nautilus Biotechnology: Contrarian Proteoformics Play After The Recent Pullback

Nautilus Biotechnology Inc (NAUT) Q2 2026 Earnings Call Highlights: Strategic Shifts and ...

Nautilus Biotechnology Q2 Earnings Call Highlights

Nautilus Biotechnology, Inc. (NAUT) Q2 2026 Earnings Call Transcript

Nautilus Biotechnology Reports Second Quarter 2026 Financial Results

Nautilus Biotechnology Q2 EPS $(0.11) Beats $(0.14) Estimate, Sales $190.000K

Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026

Nautilus Biotechnology (NASDAQ:NAUT) Is In A Good Position To Deliver On Growth Plans

Nautilus Biotechnology Inc (NAUT) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ...

Nautilus Biotechnology, Inc. (NAUT) Q1 2026 Earnings Call Transcript

Nautilus Biotechnology Q1 Earnings Call Highlights

Nautilus Biotechnology Reports First Quarter 2026 Financial Results

Nautilus Biotechnology Reports Q1 2026 Results: Full Earnings Call Transcript

Nautilus Biotechnology Q1 EPS $(0.12) Beats $(0.17) Estimate

Here is Why Nautilus Biotechnology (NAUT) is One of the Best Life Sciences Penny Stocks to Buy